V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20207230 | 20077481 | 1.74 | 57 | null | 2018-01-21 | 2018-02-15 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100129524 |
| 20207232 | 20077482 | 1.67 | 56 | null | 2017-07-12 | 2017-07-31 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100322709 |
| 20207235 | 20077483 | 1.63 | 91.2 | Neo-adjuvant (N) | 2019-12-03 | 2019-12-10 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 100899513 |
| 20207240 | 20077484 | 1.73 | 65.5 | 03 | 2017-06-20 | 2017-07-02 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100747646 |
| 20207241 | 20077485 | 1.8 | 122.7 | null | 2019-06-23 | 2019-07-12 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100431672 |
| 20207242 | 20077486 | 1.76 | 96.1 | Neo-adjuvant (N) | 2019-09-12 | 2019-10-15 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100252355 |
| 20207245 | 20077487 | 1.62 | 45 | null | 2018-05-25 | 2018-06-08 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101537021 |
| 20207247 | 20077488 | 1.9 | 91 | Curative (C) | 2018-12-21 | 2018-12-28 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 101126581 |
| 20207248 | 20077489 | 1.7 | 58 | null | 2019-05-29 | 2019-06-09 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100332949 |
| 20207249 | 20077490 | 1.63 | 48.4 | Curative (C) | 2017-12-09 | 2017-12-28 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101045738 |
| 20207250 | 20077491 | 1.66 | 119 | null | 2020-05-16 | 2020-05-23 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101087176 |
| 20207252 | 20077492 | 1.81 | 119 | 03 | 2018-06-12 | 2018-07-08 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100273131 |
| 20207254 | 20077493 | 1.68 | 91.6 | Curative (C) | 2018-07-13 | 2018-08-09 | Doxorubicin chemoembolisation | null | Y | DOXORUBICIN EMBOLISATION | 100712509 |
| 20207257 | 20077494 | 1.62 | 80.1 | null | 2017-08-23 | 2017-08-23 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101234060 |
| 20207258 | 20077495 | null | 73 | null | null | 2019-05-30 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101300494 |
| 20207259 | 20077496 | 1.63 | 84.2 | Palliative (P) | 2018-06-04 | 2018-06-17 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101799931 |
| 20207262 | 20077497 | 1.76 | 65.7 | Palliative (P) | 2018-11-05 | 2018-11-20 | Capecitabine + Carboplatin + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101649406 |
| 20207263 | 20077498 | 1.57 | 60.2 | Neo-adjuvant (N) | 2018-11-26 | 2018-12-02 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101724652 |
| 20207269 | 20077499 | 1.69 | 64 | Curative (C) | 2017-08-27 | 2017-09-15 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100212333 |
| 20207270 | 20077500 | 1.62 | 85.7 | null | 2018-02-01 | 2018-02-08 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100603313 |
| 20207272 | 20077501 | 1.7 | 70.3 | Curative (C) | 2019-04-13 | 2019-06-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100701440 |
| 20207273 | 20077502 | 1.7 | 66.4 | Neo-adjuvant (N) | 2016-05-31 | 2016-05-31 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101007979 |
| 20207276 | 20077503 | null | null | Palliative (P) | 2017-12-06 | 2017-12-06 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100647232 |
| 20207277 | 20077504 | 1.51 | 71.4 | Palliative (P) | 2017-06-05 | 2017-06-07 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100110347 |
| 20207278 | 20077505 | 1.63 | 72.3 | Adjuvant (A) | 2019-04-30 | 2019-04-30 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101613456 |
| 20207287 | 20077506 | 1.64 | 97 | null | 2016-12-28 | 2017-01-05 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101098989 |
| 20207288 | 20077507 | 1.78 | 75.7 | null | 2017-11-01 | 2017-11-24 | Capecitabine (21days) + Carboplatin | N | null | TRIAL UNSPECIFIED | 101584455 |
| 20207289 | 20077508 | 1.73 | 75.2 | null | 2019-11-17 | 2019-11-24 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 101406617 |
| 20207294 | 20077509 | 1.65 | 76.6 | Palliative (P) | 2016-05-08 | 2016-05-15 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100887687 |
| 20207303 | 20077510 | 1.7 | 0 | Palliative (P) | 2016-06-01 | 2016-07-04 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101292975 |
| 20207337 | 20077511 | 1.61 | 65.2 | Neo-adjuvant (N) | 2018-08-16 | 2018-08-26 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 101448385 |
| 20207343 | 20077512 | 0 | 104 | Palliative (P) | 2018-03-21 | 2018-03-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100748836 |
| 20207344 | 20077513 | 1.67 | 76 | Palliative (P) | 2017-07-30 | 2017-08-17 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 101047788 |
| 20207348 | 20077514 | 1.61 | 70.9 | Palliative (P) | 2019-08-31 | 2019-09-03 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101321384 |
| 20207350 | 20077515 | 0 | 0 | Neo-adjuvant (N) | null | 2017-03-02 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100846198 |
| 20207353 | 20077516 | 0 | 0 | Palliative (P) | 2016-09-16 | 2016-09-24 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100987258 |
| 20207354 | 20077517 | 1.7 | 78.6 | Palliative (P) | 2017-09-13 | 2017-09-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100108038 |
| 20207355 | 20077518 | 1.6 | 54.4 | Neo-adjuvant (N) | 2019-10-15 | 2019-12-11 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100364924 |
| 20207372 | 20077519 | 1.76 | 84 | Neo-adjuvant (N) | null | 2020-02-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100427467 |
| 20207382 | 20077520 | 1.79 | 74.6 | Curative (C) | 2018-02-07 | 2018-02-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100817817 |
| 20207387 | 20077521 | null | 92.3 | 03 | null | 2020-02-23 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100411357 |
| 20207389 | 20077522 | 0 | 0 | Palliative (P) | 2017-08-16 | 2017-09-16 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 101724440 |
| 20207392 | 20077523 | 1.73 | 74.8 | Palliative (P) | 2018-04-04 | 2018-04-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100728521 |
| 20207394 | 20077524 | 1.75 | 80.1 | Palliative (P) | 2018-01-21 | 2018-01-30 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101122460 |
| 20207395 | 20077525 | 1.76 | 56 | null | 2016-03-15 | 2016-03-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100720650 |
| 20207401 | 20077526 | 1.59 | 72 | 03 | 2016-03-19 | 2016-03-19 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 101150787 |
| 20207404 | 20077527 | 1.62 | 80.8 | Neo-adjuvant (N) | 2020-03-28 | 2020-04-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100845463 |
| 20207406 | 20077528 | 1.59 | 56 | Palliative (P) | 2019-04-07 | 2019-05-05 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101852274 |
| 20207411 | 20077529 | 1.83 | 85 | Palliative (P) | 2020-03-13 | 2020-03-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101781015 |
| 20207412 | 20077530 | 1.49 | 49.4 | Curative (C) | 2018-05-25 | 2018-05-25 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100903418 |